Iron Deficiency Anemia: Evaluation and Management
Medically Reviewed by Dr. M. Salar Raza | Official SCFHS 2026 Blueprint
Clinical Pathway
The evaluation of anemia begins with a complete blood count (CBC). A microcytic, hypochromic anemia (low MCV, low MCH) is highly suggestive of iron deficiency anemia (IDA), especially in women of childbearing age with a history of heavy menses. The diagnosis is confirmed by iron studies showing low serum iron, low ferritin, and high total iron-binding capacity (TIBC). The first-line treatment is oral iron supplementation (e.g., ferrous sulfate). Re-evaluation of hemoglobin levels should occur after 2-4 weeks to ensure an adequate response.
Clinical Reasoning
Heavy menstrual bleeding is a very common cause of chronic blood loss, leading to depletion of iron stores. As iron is essential for hemoglobin synthesis, its deficiency results in the production of smaller (microcytic) and paler (hypochromic) red blood cells. The classic iron panel for IDA reveals a depleted iron store (low ferritin), low circulating iron, and a compensatory increase in the liver's production of transferrin (high TIBC). Oral iron is the safest and most cost-effective initial therapy, with parenteral iron reserved for intolerance or malabsorption.
Sample MCQ
A 28-year-old woman complains of progressive fatigue and weakness over the past 3 months. She reports heavy menstrual periods. Laboratory tests show a hemoglobin of 9.2 g/dL, MCV of 72 fL, and MCH of 24 pg. Which of the following is the most likely diagnosis?
- AThalassemia minor
- BVitamin B12 deficiency
- CIron deficiency anemia
- DAnemia of chronic disease
Correct Answer: Iron deficiency anemia
The patient presents with symptoms of anemia and a history of menorrhagia, a common cause of chronic blood loss. The laboratory findings show a microcytic (low MCV) and hypochromic (low MCH) anemia, which is the classic presentation of Iron Deficiency Anemia. Thalassemia minor can also present with microcytosis but usually has a normal or elevated RBC count and normal iron studies. Vitamin B12 deficiency causes a macrocytic anemia. Anemia of chronic disease is typically normocytic, or mildly microcytic, with normal or high ferritin.
Related Clinical Topics
Acute Otitis Media (AOM) in Pediatrics: Diagnosis and Management
Acute Otitis Media (AOM) is characterized by acute onset of symptoms (fever, ear pain) and signs of middle ear inflammation, such as a bulging tympanic membrane. The first-line antibiotic therapy for AOM is Amoxicillin, given at a high dose (80-90 mg/kg/day). Amoxicillin is effective against the most common bacterial pathogen, Streptococcus pneumoniae. If the patient has been treated with amoxicillin in the past 30 days, or has concurrent purulent conjunctivitis, Amoxicillin-clavulanate is preferred to cover beta-lactamase-producing organisms like H. influenzae.
AIDS
AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.
Bradycardia
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks